Hutchin Hill Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-19,400
Closed -$1.81M 420
2017
Q3
$1.81M Sell
19,400
-35,900
-65% -$3.34M 0.07% 221
2017
Q2
$5.02M Buy
55,300
+1,200
+2% +$109K 0.17% 126
2017
Q1
$4.75M Buy
54,100
+2,600
+5% +$228K 0.13% 159
2016
Q4
$4.27M Buy
51,500
+2,800
+6% +$232K 0.15% 159
2016
Q3
$4.51M Buy
48,700
+3,200
+7% +$296K 0.09% 107
2016
Q2
$3.54M Buy
+45,500
New +$3.54M 0.12% 89